• About Us
    • Our Leadership Team
    • Our Board
    • Our Operating Partners & Advisors
    • Our Scientific Team
    • Locations
    • Why Us
  • Solutions
    • Solutions

    • Discovery Solutions
      • Integrated Drug Discovery
      • AI & Computational Chemistry
      • Discovery Chemistry
      • Discovery Biology
      • DMPK Services
      • Preclinical Services
    • Development Solutions
      • Process R&D
Services
      • Analytical Services
      • Process Safety
Services
      • In Silico Genotoxicity
    • Manufacturing Services and Solutions
      • Preclinical Supply
Services
      • Clinical Supply
Services
      • Commercial Supply Services
    • ‎
    • Enabling
Technologies
      • Flow Chemistry
      • Biocatalysis
    • New Modalities
      • TPD
        • AUTAC
        • Molecular Glues
        • LYTAC
        • PROTAC
        • Other TPD Modalities
  • Products
    • API Portfolio
  • Careers
  • News & Events
    • News & Events

    • Insights
      • Blogs
      • White Papers
      • Brochures
    • Events
      • Upcoming Events
    • Media
      • Videos
      • Awards
      • Press Release
  • Contact Us
PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group

PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group

by abishek | Oct 15, 2025 | Media, API, Press Releases

PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group April 28, 2023 We are pleased to announce that today PI Health Sciences has acquired Archimica S.p.A (headquarter in Lodi, Italy). PI Health Sciences will provide to Archimica the...
PI Health Sciences Announces Strategic Collaboration with Cresset to Deploy Torx® Software, Accelerating Innovation in Drug Discovery

PI Health Sciences Announces Strategic Collaboration with Cresset to Deploy Torx® Software, Accelerating Innovation in Drug Discovery

by abishek | May 15, 2025 | Insights, IDD, Discovery Solutions, Blogs, Media, Press Releases

Mumbai, India – May 15, 2025 – PI Health Sciences (PIHS), a leading global provider of integrated drug discovery and development solutions and a wholly owned subsidiary of PI Industries, today announced a strategic collaboration with Cresset to implement Torx®...
  • Discovery Solutions
    • Integrated Drug Discovery
    • AI & Computational Chemistry
    • Discovery Chemistry
    • Discovery Biology
    • DMPK Services
    • Preclinical Services
  • Development Solutions
    • Process R&D
Services
    • Analytical Services
    • Process Safety
Services
    • In Silico Genotoxicity
  • Manufacturing Solutions
    • Preclinical Supply

    • Clinical Supply

    • Commercial Supply
  • Enabling
Technologies
    • Flow Chemistry
    • Biocatalysis
  • New Modalities
    • TPD
      • AUTAC
      • Molecular Glues
      • LYTAC
      • PROTAC
      • Other TPD Modalities
© 2023 PI Health Sciences Ltd. All rights reserved.

Developed By Luxeveda

  • Privacy Policy
  • Posh Policy
  • Disclaimer
  • Code of Conduct
  • Investors
  • Terms and Conditions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Privacy Policy

Posh Policy

Disclaimer

Code of Conduct

Investors

Terms and Conditions

© 2023 PI Health Sciences Ltd. All rights reserved.

Developed By Luxeveda